Ying-yun Guan
280 South Chongqing Road
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Dbl family RhoGEFs in cancer: different roles and targeting strategies.
Journal: Biochemical pharmacology
Published: January 26, 2024
Oncolytic Peptide-Nanoplatform Drives Oncoimmune Response and Reverses Adenosine-Induced Immunosuppressive Tumor Microenvironment.
Journal: Advanced healthcare materials
Published: October 09, 2023
FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer.
Journal: Oncoimmunology
Published: June 01, 2023
Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway.
Journal: Frontiers in pharmacology
Published: March 19, 2021
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study.
Journal: Frontiers in pharmacology
Published: May 12, 2020
A Tumor Vascular-Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 08, 2018
Alantolactone, a sesquiterpene lactone, inhibits breast cancer growth by antiangiogenic activity via blocking VEGFR2 signaling.
Journal: Phytotherapy research : PTR
Published: May 14, 2017
Natural Products with Antiangiogenic and Antivasculogenic Mimicry Activity.
Journal: Mini reviews in medicinal chemistry
Published: January 22, 2015
Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Journal: Biomaterials
Published: August 20, 2014
Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
Journal: Toxicology and applied pharmacology
Published: July 12, 2014
Last Updated: 09/26/2026